BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• SyntheticMR Partners with Hyland to Utilize PACSgear Modlink Software

  SyntheticMR’s mission is to make quantitative imaging solutions the standard of care to support more precise diagnosis, reliable monitoring and deeply personalized treatment strategies.

  February 8, 2022

   · 

  2 min read
• Drug Development

  Alzheon Reports Industry-Leading Disease Modifying Effects from Phase 2 Biomarker Trial of Oral Tablet ALZ-801 (Valiltramiprosate) in Patients with Early Alzheimer’s Disease

  Alzheon, Inc. reported a clinically relevant and statistically significant plasma biomarker reduction and memory improvement in Alzheimer’s patients following 6 months of treatment with oral tablet ALZ-801 in its Phase 2 biomarker trial.

  February 8, 2022

   · 

  11 min read
• Business

  Centene Corporation Reports 2021 Results

  Centene Corporation announced its financial results for the fourth quarter and year ended December 31, 2021, reporting diluted earnings per share of $1.01 and $2.28, respectively, and adjusted diluted EPS of $1.01 and $5.15, respectively.

  February 8, 2022

   · 

  30 min read
• Genetown

  BeiGene to Present at the Guggenheim Healthcare Talks - 2022 Oncology Conference

  BeiGene, Ltd., a global science-driven biotechnology company, announced that the Company will participate in the Guggenheim Healthcare Talks, 2022 Oncology Conference on Thursday, February 10, 2022 at 9:00 a.m. ET.

  February 8, 2022

   · 

  1 min read
• Business

  Merakris and Dept. of Veterans Affairs Sign CRADA Agreement – Clinical Trial for Dermacyte® Wound Care Product To Begin Soon

  Merakris Therapeutics announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Veterans Affairs (VA) to test its investigational drug product, Dermacyte® Amniotic Wound Care Liquid.

  February 8, 2022

   · 

  4 min read
• Cingulate Provides 2022 Clinical Plan for CTx-1301, an Investigational Medication for Attention Deficit/Hyperactivity Disorder (ADHD)Expedited Clinical Program Reduces Capital Requirements

  Cingulate Inc. today announced updates to its 2022 clinical program for its lead candidate CTx-1301, an investigational asset for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).

  February 8, 2022

   · 

  5 min read
• Rheumatoid Arthritis Stem Cell Therapy Market Global Industry Analysis and Key Trends

  Rheumatoid arthritis is an inflammatory disease of the body’s supportive tissues, usually affecting an individual’s toes and fingers.

  February 8, 2022

   · 

  5 min read
• Micro Syringes Market: Surge in applications of micro syringes is projected to present significant opportunities in the global market

  Micro syringes are devices used for medical purpose such as fluid injection and extracting fluid from the body. These syringes have a hollow and cylindrical shape.

  February 8, 2022

   · 

  5 min read
• Global Dental Air Polishing Market Key Trends and New Developments

  Air polishing refers to the utilization of sodium bicarbonate or glycine powder, water, and compressed air to cause disruption in the formation of oral biofilm.

  February 8, 2022

   · 

  6 min read
• Blood Collection Monitor Market: Surge in number of surgical procedures carried out across the world is expected to drive the market

  Blood collection monitor is a compact medical device. It is used to monitor homogenous mixing of blood and anticoagulant during collection of blood from a donor.

  February 8, 2022

   · 

  5 min read